A New Treatment Landscape for RCC: Association of the Human Microbiome with Improved Outcomes in RCC

SIMPLE SUMMARY: Renal cell carcinoma (RCC) is a highly vascularized and immunogenic tumor, and its treatment has been revolutionized by the development of immune-checkpoint inhibitors. However, the clinical benefit of these agents is limited in patients with metastatic disease. The microbiome has em...

Descripción completa

Detalles Bibliográficos
Autores principales: Piao, Xuan-Mei, Byun, Young Joon, Zheng, Chuang-Ming, Song, Sun Jin, Kang, Ho Won, Kim, Won Tae, Yun, Seok Joong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913391/
https://www.ncbi.nlm.nih.gov/pubmed/36765892
http://dx.doi.org/10.3390/cancers15030935

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913391/
https://www.ncbi.nlm.nih.gov/pubmed/36765892
http://dx.doi.org/10.3390/cancers15030935

Ejemplares similares